Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models.
Saved in:
| Title: | Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models. |
|---|---|
| Authors: | Gomez Rodriguez Y; Pavillon de Recherche Appliquée sur le Cancer (PRAC), Université de Sherbrooke, Sherbrooke, QC, Canada., Oliva Arguelles B; Pharmaceutical Department, Laboratory of Cancer Biology, Center for Genetic Engineering and Biotechnology (CIGB), Cubanacan, P.O. Box 6162, 10600, Havana, Cuba. brizaida.oliva@gmail.com., Riera-Romo M; Leslie Dan Faculty of Pharmacy, University of Toronto, 70 Downswiew avenue, Toronto, ON, M3M1E2, Canada., Fernandez-De-Cossio J; Department of Bioinformatics, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Garay HE; Peptide Synthesis Division, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba., Fernandez Masso J; Pharmaceutical Department, Laboratory of Cancer Biology, Center for Genetic Engineering and Biotechnology (CIGB), Cubanacan, P.O. Box 6162, 10600, Havana, Cuba., Guerra Vallespi M; Pharmaceutical Department, Laboratory of Cancer Biology, Center for Genetic Engineering and Biotechnology (CIGB), Cubanacan, P.O. Box 6162, 10600, Havana, Cuba. |
| Source: | Molecular biology reports [Mol Biol Rep] 2022 Apr; Vol. 49 (4), pp. 3197-3212. Date of Electronic Publication: 2022 Jan 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-4978 |
|---|---|
| DOI: | 10.1007/s11033-022-07152-3 |
